☰Menu

CyberKnife Treatment for Prostate Cancer

Author: - View Credentials
Published: 3 Sep 2010 - Updated: 2 Aug 2024
Publication Type: Informative

Table of Contents:
Synopsis - Overview - Related Content

Synopsis

CyberKnife radiosurgery treatment for prostate cancer is fast effective has no side effects and is non-invasive.

Overview

CyberKnife radiosurgery treatment for prostate cancer is rapid, effective and has no side effects, with the added benefit of being non-invasive.

Prostate Cancer is diagnosed in more than a quarter of a million men each year in the U.S. Treatment options in existence which are non-invasive with little to no side effects are practically none. CyberKnife treatment for prostate cancer literally kills the cancer cells with a precisely targeted beam of radiation that does not affect surrounding tissue or organs.

CyberKnife Treatment requires:

Incorporating a compact, lightweight linear accelerator mounted on a robotic arm, the CyberKnife provides unparalleled flexibility in targeting tumors and lesions. Advanced image guidance technology tracks patient and target position during treatment, ensuring sub millimeter accuracy.

The CyberKnife with its Dynamic Tracking Software is cleared by the FDA to provide radio-surgery for lesions anywhere in the body when radiation treatment is indicated. The CyberKnife has often been used to radio-surgically treat otherwise un-treatable tumors or inoperable tumors. The system treats tumors at body sites unreachable by other stereotactic systems.

Ian C. Langtree Author Credentials: Ian C. Langtree is a writer, editor, and the founder and Editor-in-Chief of Disabled World, which he established in 2004 as one of the longest-running independent resources for disability news and information. Over more than two decades, he has written and edited thousands of articles on disability rights, health, accessibility, and assistive technology. Drawing on a global perspective shaped by extensive travel and lived experience, Ian is a committed advocate of the Social Model of Disability, the framework developed by disabled activists in the 1970s that focuses on removing societal barriers rather than on individual impairments. His writing is grounded in that framework and in a lasting commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his .

Renaming Low-Risk Prostate Cancer May Save Lives Each Year

Relabeling Grade Group 1 prostate cancer as a precancerous condition could curb overtreatment, increase PSA screening and prevent deaths, a UCLA-led model finds. Published: 1 Jul 2026.

Two-Week Radiotherapy Matches Eight-Week Prostate Cancer Treatment

A decade-long phase 3 trial shows 2 week radiotherapy is as safe and effective as 8 week treatment for prostate cancer, with similar survival and side effects. Published: 5 May 2025.

PI-RADS Score Chart: Prostate MRI Cancer Assessment

PI-RADS is a standardized 1 to 5 scoring system that uses prostate mpMRI to assess the likelihood of clinically significant cancer and guide biopsies. Published: 27 Jan 2025.

Gleason Scores and Grade Groups in Prostate Cancer Explained

Learn how Gleason scores and Grade Groups 1 to 5 rate prostate cancer aggressiveness, why 3+4 differs from 4+3, and how the grade guides treatment choices. Published: 26 Jan 2025.

See the full list of publications

Share or cite this page:

<a href="https://www.disabled-world.com/health/cancer/prostate/cyberknife-treatment.php">CyberKnife Treatment for Prostate Cancer</a>: CyberKnife radiosurgery treatment for prostate cancer is fast effective has no side effects and is non-invasive.

While we aim to provide accurate, up-to-date information, our content is for general informational purposes only and is not a substitute for professional advice. Consult a qualified professional about your specific situation.

BACK TO TOP